Express, Inc. (EXPR)Hedge Funds Are Snapping Up

As one would reasonably expect, some big names have jumped into Express, Inc. (NYSE:EXPR) headfirst. Samlyn Capital, managed by Robert Pohly, established a position in Express, Inc. (NYSE:EXPR). Samlyn Capital had $24.3 million invested in the company at the end of the quarter. David Keidan’s Buckingham Capital Management also initiated an $21.8 million position during the quarter. The following funds were also among the new EXPR investors: Robert B. Gillam’s McKinley Capital Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, and Peter Algert and Kevin Coldiron’s Algert Coldiron Investors.

Let’s now review hedge fund activity in other stocks similar to Express, Inc. (NYSE:EXPR). These stocks are Pacira Pharmaceuticals Inc (NASDAQ:PCRX), WebMD Health Corp. (NASDAQ:WBMD), Lannett Company, Inc. (NYSE:LCI), and Invesco Mortgage Capital Inc (NYSE:IVR). This group of stocks’ market caps resemble EXPR’s market cap.

As you can see these stocks had an average of 23 hedge funds with bullish positions and the average amount invested in these stocks was $285 million. That figure was $269 million in EXPR’s case. Pacira Pharmaceuticals Inc (NASDAQ:PCRX) is the most popular stock in this table. On the other hand Invesco Mortgage Capital Inc (NYSE:IVR) is the least popular one with only 13 bullish hedge fund positions. Compared to these stocks, Express, Inc. (NYSE:EXPR) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.